Cellular origin(s) of chronic lymphocytic leukemia: Cautionary notes and additional considerations and possibilities

Nicholas Chiorazzi, Manlio Ferrarini

Research output: Contribution to journalArticle

Abstract

Several cell types have been suggested as giving rise to chronic lymphocytic leukemia (CLL), and these suggestions have reflected the sophistication of technology available at the time. Although there is no consensus as to the normal cellular counterpart(s) in the disease, an antigen-experienced B lymphocyte appears required based on surface membrane phenotypes and gene expression profiles. However, what is still unclear is whether a single or multiple normal precursors were stimulated to evolve into CLL and at what stage(s) this occurred. A unifying, parsimonious theory is that CLL clones with either mutated or unmutated IGHVs derive from marginal zone B cells. However, evidence for remarkably similar B-cell receptor amino acid sequence and striking differences in polyantigen and autoantigen-binding activity, found in some but not all CLL clones, challenge a single-cell derivation for CLL. In this Perspective, we summarize data regarding normal counterparts of CLL cells and suggest that a multistep process of leukemogenesis is important to consider when assigning a cellular origin for this disease. Finally, although available data do not definitively identify the cell(s) of origin, we offer possibilities for single- and multiple-cell origin models as straw men that can be improved on and hopefully lead to final answers to this puzzle.

Original languageEnglish
Pages (from-to)1781-1791
Number of pages11
JournalBlood
Volume117
Issue number6
DOIs
Publication statusPublished - Feb 10 2011

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Amino Acid Receptors
Cells
Lymphocytes
Autoantigens
Gene expression
B-Lymphocytes
Membranes
Antigens
Clone Cells
Transcriptome
Amino Acid Sequence
Technology
Phenotype

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Cellular origin(s) of chronic lymphocytic leukemia : Cautionary notes and additional considerations and possibilities. / Chiorazzi, Nicholas; Ferrarini, Manlio.

In: Blood, Vol. 117, No. 6, 10.02.2011, p. 1781-1791.

Research output: Contribution to journalArticle

Chiorazzi, Nicholas ; Ferrarini, Manlio. / Cellular origin(s) of chronic lymphocytic leukemia : Cautionary notes and additional considerations and possibilities. In: Blood. 2011 ; Vol. 117, No. 6. pp. 1781-1791.
@article{d3a5617dec374fcca2663b9393ac743b,
title = "Cellular origin(s) of chronic lymphocytic leukemia: Cautionary notes and additional considerations and possibilities",
abstract = "Several cell types have been suggested as giving rise to chronic lymphocytic leukemia (CLL), and these suggestions have reflected the sophistication of technology available at the time. Although there is no consensus as to the normal cellular counterpart(s) in the disease, an antigen-experienced B lymphocyte appears required based on surface membrane phenotypes and gene expression profiles. However, what is still unclear is whether a single or multiple normal precursors were stimulated to evolve into CLL and at what stage(s) this occurred. A unifying, parsimonious theory is that CLL clones with either mutated or unmutated IGHVs derive from marginal zone B cells. However, evidence for remarkably similar B-cell receptor amino acid sequence and striking differences in polyantigen and autoantigen-binding activity, found in some but not all CLL clones, challenge a single-cell derivation for CLL. In this Perspective, we summarize data regarding normal counterparts of CLL cells and suggest that a multistep process of leukemogenesis is important to consider when assigning a cellular origin for this disease. Finally, although available data do not definitively identify the cell(s) of origin, we offer possibilities for single- and multiple-cell origin models as straw men that can be improved on and hopefully lead to final answers to this puzzle.",
author = "Nicholas Chiorazzi and Manlio Ferrarini",
year = "2011",
month = "2",
day = "10",
doi = "10.1182/blood-2010-07-155663",
language = "English",
volume = "117",
pages = "1781--1791",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - Cellular origin(s) of chronic lymphocytic leukemia

T2 - Cautionary notes and additional considerations and possibilities

AU - Chiorazzi, Nicholas

AU - Ferrarini, Manlio

PY - 2011/2/10

Y1 - 2011/2/10

N2 - Several cell types have been suggested as giving rise to chronic lymphocytic leukemia (CLL), and these suggestions have reflected the sophistication of technology available at the time. Although there is no consensus as to the normal cellular counterpart(s) in the disease, an antigen-experienced B lymphocyte appears required based on surface membrane phenotypes and gene expression profiles. However, what is still unclear is whether a single or multiple normal precursors were stimulated to evolve into CLL and at what stage(s) this occurred. A unifying, parsimonious theory is that CLL clones with either mutated or unmutated IGHVs derive from marginal zone B cells. However, evidence for remarkably similar B-cell receptor amino acid sequence and striking differences in polyantigen and autoantigen-binding activity, found in some but not all CLL clones, challenge a single-cell derivation for CLL. In this Perspective, we summarize data regarding normal counterparts of CLL cells and suggest that a multistep process of leukemogenesis is important to consider when assigning a cellular origin for this disease. Finally, although available data do not definitively identify the cell(s) of origin, we offer possibilities for single- and multiple-cell origin models as straw men that can be improved on and hopefully lead to final answers to this puzzle.

AB - Several cell types have been suggested as giving rise to chronic lymphocytic leukemia (CLL), and these suggestions have reflected the sophistication of technology available at the time. Although there is no consensus as to the normal cellular counterpart(s) in the disease, an antigen-experienced B lymphocyte appears required based on surface membrane phenotypes and gene expression profiles. However, what is still unclear is whether a single or multiple normal precursors were stimulated to evolve into CLL and at what stage(s) this occurred. A unifying, parsimonious theory is that CLL clones with either mutated or unmutated IGHVs derive from marginal zone B cells. However, evidence for remarkably similar B-cell receptor amino acid sequence and striking differences in polyantigen and autoantigen-binding activity, found in some but not all CLL clones, challenge a single-cell derivation for CLL. In this Perspective, we summarize data regarding normal counterparts of CLL cells and suggest that a multistep process of leukemogenesis is important to consider when assigning a cellular origin for this disease. Finally, although available data do not definitively identify the cell(s) of origin, we offer possibilities for single- and multiple-cell origin models as straw men that can be improved on and hopefully lead to final answers to this puzzle.

UR - http://www.scopus.com/inward/record.url?scp=79951498701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951498701&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-07-155663

DO - 10.1182/blood-2010-07-155663

M3 - Article

C2 - 21148333

AN - SCOPUS:79951498701

VL - 117

SP - 1781

EP - 1791

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -